QIAGEN Adds Novel Technology for Haplotype Specific Extraction (HSE)
16-Feb-2005 -
QIAGEN N.V. announced that its wholly owned subsidiary GenoVision Inc. has licensed a novel technology for haplotype specific extraction of DNA (HSE) from Generation Biotech, LLC. Under the terms of the license agreement QIAGEN's wholly owned subsidiary received exclusive rights for the worldwide ...
chromosomes
diagnostics
diseases
+4